Concept paper on the development of a reflection paper on the use of External controls for evidence generation in regulatory decision-making

Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 6, Status: Authorised

EMA, AMA and African regulatory authorities join forces on Ebola outbreak response

Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 24, Status: Authorised

EMA’s API general terms and conditions of use - Terms of use

Meeting summary - Medicine shortages SPOC working party meeting 15 April 2026

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 2, Status: Authorised

Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (II-40)

Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Date of authorisation: 06/05/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Zandoriah, teriparatide, Date of authorisation: 27/04/2026, Status: Authorised